drugset / Trial / NCT01241643
Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a Phase II multicenter, open-labeled, controlled, randomized study assessing weekly doses of Interleukin-7 (CYT107)
Timeline
- Start
- 2010-09
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Interleukin-7 | Protein / enzyme biologic | 20 ug/kg | Subcutaneous |